Routine antenatal anti-D prophylaxis, a key preventative blood product used to reduce risk in hemolytic disease of the fetus ...

Early detection and treatment reduce fetal death and severe anemia, and nipocalimab can help detect HDFN earlier and prevent ...

Gel microcolumn assay (GMA) effectively identifies pregnancies at high risk for severe HDFN, but its false positivity rate ...

Umbilical cord blood (UCB) may offer a safe transfusion source for treating hemolytic disease of the fetus and newborn (HDFN) ...

If you have to travel to get your infant specialty care, you will likely benefit from planning ahead to avoid any unnecessary ...

Learn about the tests often performed on infants with HDFN, including what they measure and how many will be required.

Learn more about haptoglobin, including what it is, how it works and why infants with HDFN often have low haptoglobin levels.

Accurate detection of fetomaternal hemorrhage is essential to prevent hemolytic disease of the fetus and newborn (HDFN) in ...

A recent study found that an anti-Kell antibody level of eight can be used to reliably identify patients at risk of severe ...

Learn more about rebound hyperbilirubinemia in newborns, including its causes, symptoms and treatment options.

Nipocalimab is also being studied as a potential treatment for HDFN. Johnson & Johnson’s nipocalimab-aa4hu, marketed as IMAAVY, has been approved by the U.S. Food and Drug Administration (FDA) for ...